论文部分内容阅读
近来,葛兰素史克公司旗下治疗糖尿病的“明星药物”文迪雅(罗格列酮)因在欧洲和美国市场分别遭禁和限用而掀起轩然大波。笔者发现,中外媒体报道的事
Recently, GlaxoSmithKline’s “Star Drugs” Avandia (Rosiglitazone), which treats diabetes, has caused an uproar in both banned and restricted markets in Europe and the United States. I found that Chinese and foreign media reports